✦ LIBER ✦

Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis

✍ Scribed by Henrik Ekberg; Lars Bäckman; Gunnar Tufveson; Gunnar Tydén; Björn Nashan; Flavio Vincenti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daclizumab prevents acute rejection and

✍ H. Ekberg; L. Bäckman; G. Tufveson; G. Tydén; B. Nashan; F. Vincenti 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 93 KB

Zenapax (daclizumab) reduces the inciden

✍ H Ekberg; L Bäckman; G Tufveson; G Tydén 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 136 KB